RVL Pharmaceuticals plc·4

Jan 26, 4:31 PM ET

Klein Christopher 4

4 · RVL Pharmaceuticals plc · Filed Jan 26, 2022

Insider Transaction Report

Form 4
Period: 2022-01-24
Klein Christopher
General Counsel and Secretary
Transactions
  • Tax Payment

    Ordinary Shares

    2022-01-24$1.13/sh9,607$10,856201,755 total

Documents

1 file
  • 4
    tm223506-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT